品牌升級助力獲客 平安好醫生(1833.HK)近1個月累漲超70%
格隆匯4月20日丨
平安好醫生(1833.HK)近期持續上漲,今日大漲8.96%報104.6港元,盤中再創歷史新高價104.8港元,最新總市值1116億港元。該股自3月20日啟動上漲行情至今,1個月期間累漲達75%。
近期,平安好醫生進行品牌升級,推出全新的slogan:拿起手機問醫生,名醫秒回送藥快,清晰地勾勒出平安好醫生“名醫問診秒級響應”、“閃電送藥”等服務優勢。疫情期間,伴隨着在線醫療需求激增,更多用户使用平安好醫生APP後,感受到在線看病買藥的便利性,並且逐步形成品牌習慣。據《新聞聯播》報道,疫情發生以來到4月8日期間,平安好醫生累計訪問人次達11.1億,新註冊用户量增長10倍。
2019年財報顯示,平安好醫生APP已經發展成為3億人都在用的在線醫療APP,並在疫情之後,成為高速增長的數字經濟代表公司,受到更多消費者和投資方的關注。
新的廣告宣傳片也向外界釋放信號——平安好醫生正不斷髮揮優勢,夯實在線醫療核心業務,為3億用户提供高效率、高品質的醫療健康服務。
目前,平安好醫生的AI輔助診療系統已經覆蓋3000種疾病,積累了超過6.7億人次的海量真實的諮詢數據,能夠極大地幫助醫生提升問診效率,實現問診“秒迴應”。同時,依託平安好醫生覆蓋全國的醫療健康服務生態網絡,用户足不出户就能享受到1小時送藥到家的便利服務。
據第三方數據平台易觀報告,平安好醫生APP的流量和活躍度穩居國內互聯網醫療健康平台首位。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.